Qingxin Mu

Qingxin Mu

Department of Pharmaceutics, University of Washington
在 uw.edu 的电子邮件经过验证
被引用次数：4418
cancer nanotherapeutics drug delivery combination therapy nano-bio interactions
Dr. Arghya Adhikary

Dr. Arghya Adhikary

Assistant Professor, Department of Life Science and Biotechnology, Jadavpur University
在 jadavpuruniversity.in 的电子邮件经过验证
被引用次数：3149
Cancer cell signalling in apoptosis and … miRNA regulation in cancer cancer nanotherapeutics.
Sin-Yeang Teow (Ronald)

Sin-Yeang Teow (Ronald)

Wenzhou-Kean University; Kean University
在 kean.edu 的电子邮件经过验证
被引用次数：3080
cancer nanotherapeutics cancer biology
Melika Sarem

Melika Sarem

ReLive Therapeutics, Inc.
在 makro.uni-freiburg.de 的电子邮件经过验证
被引用次数：596
Biomineralization Regenerative Medicine Cell-Material Interface Cell Signaling Cancer Nanotherapeutics
shanid mohiyuddin

shanid mohiyuddin

University of Missouri
在 missouri.edu 的电子邮件经过验证
被引用次数：525
Hematological malignancies Bone marrow transplantation GVHD Cancer nanotherapeutics
Aqib Iqbal Dar, PhD

Aqib Iqbal Dar, PhD

Postdoctoral Research Associate, Washington State University, Pullman, United States
在 wsu.edu 的电子邮件经过验证
被引用次数：196
Nanomedicine Wound Healing Cancer-Nanotherapeutics Protein-NP interaction Drug Delivery
Vaibhav Saxena, Ph.D.

Vaibhav Saxena, Ph.D.

Catalent Pharma Solutions
被引用次数：163
Oral Solids Soft gels Mitochondrial medicine Cancer nanotherapeutics
Gowsalya K

Gowsalya K

Research scholar
在 buc.edu.in 的电子邮件经过验证
被引用次数：72
Cancer nanotherapeutics
Mahendran Jaganathan

Mahendran Jaganathan

Institute of Nanoscience and technology
在 inst.ac.in 的电子邮件经过验证
被引用次数：12
Cancer Nanotherapeutics Pharmacology Epigenetics
Mrunalini Boddu

Mrunalini Boddu

Institute of Nano Science and Technology
在 inst.ac.in 的电子邮件经过验证
被引用次数：5
Cancer Nanotherapeutics